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Charles Handford1, Pauline Buxton2, Katie Russell3, Caitlin EA Imray4, Scott E McIntosh5, Luanne Freer6,7,
Amalia Cochran8 and Christopher HE Imray9,10*Abstract
Frostbite presentation to hospital is relatively infrequent, and the optimal management of the more severely injured
patient requires a multidisciplinary integration of specialist care. Clinicians with an interest in wilderness medicine/
freezing cold injury have the awareness of specific potential interventions but may lack the skill or experience to
implement the knowledge. The on-call specialist clinician (vascular, general surgery, orthopaedic, plastic surgeon or
interventional radiologist), who is likely to receive these patients, may have the skill and knowledge to administer
potentially limb-saving intervention but may be unaware of the available treatment options for frostbite. Over the
last 10 years, frostbite management has improved with clear guidelines and management protocols available for
both the medically trained and winter sports enthusiasts. Many specialist surgeons are unaware that patients with
severe frostbite injuries presenting within 24 h of the injury may be good candidates for treatment with either TPA
or iloprost. In this review, we aim to give a brief overview of field frostbite care and a practical guide to the hospital
management of frostbite with a stepwise approach to thrombolysis and prostacyclin administration for clinicians.
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Introduction
Frostbite is a freezing, cold thermal injury, which occurs
when tissues are exposed to temperatures below their
freezing point (typically −0.55°C, but can occur as high as
2°C) for a sustained period of time [1]. It is a condition
that has far-reaching consequences in terms of functional
morbidity to a population that are often young, fit and
healthy prior to the thermal injury. Many frostbite patients
in urban areas are homeless and/or suffer from mental
health issues. Frostbite is well documented in the military
and in countries with extreme temperatures for centuries.
The earliest documented evidence of frostbite may be a
5,000-year-old pre-Columbian mummy discovered in the
Andes [2]. The first report of mass cold injuries was
by Baron Larrey, Surgeon-in-Chief to Napoleon's Army
throughout the invasion of Russia during the winter of
1812–1813 [3]. Larrey introduced the concept that the* Correspondence: chrisimray@aol.com
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2014physiologic response to cold injuries was similar to that of
burn injuries and recognized that warming frozen tissue
was advantageous for recovery.
Today, the presentation of frostbite is increasing
within the civilian population, in particular those who
partake in winter sports such as skiing, hiking, mountain
and ice climbing [4]. The outdoors is more accessible,
and individuals with limited experience/inadequate prep-
aration and protection find themselves at risk of cold
thermal injury [5]. Vagrancy, homelessness, industrial in-
jury and malfunctioning or misuse of equipment using
NO or CO2 have also been described [6,7].
Severity of injury depends on factors such as absolute
temperature, wind chill, duration of exposure, wet/dry
cold, immersion, clothing quality and patient comorbidi-
ties such as smoking, peripheral vascular disease, neuropa-
thies, Raynaud's disease, mental health issues, substance
abuse and dementia [1,4,8,9]. Alcohol consumption is po-
tentially particularly devastating as it causes heat loss
through peripheral vasodilatation and also impairs judge-
ment. This may affect the individual's ability to seek ad-
equate shelter, compounding the injury. Amputation of
injured parts has been shown to correlate more closelyral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[9]. Anatomically, the hands and feet account for 90% of re-
ported injuries [10,11]. Frostbite can also affect the face
(nose, chin, earlobes, cheeks and lips), buttocks/perineum
(from sitting on metal seats) and penis (joggers and Nordic
skiers). Patients at the extremes of age (elderly and infants/
young children) are at greater risk because of immobility
and higher surface area-to-mass ratio (children); however,
studies show that frostbite is uncommon in these age
groups and instead is seen more commonly in adults be-
tween the ages of 30 and 49 years, most likely due to in-
creased exposure to cold or risk-taking behaviour [10,11].
Frostbite can result in a wide spectrum of injury, ranging
from complete resolution without significant sequelae to
major limb amputation and its functional consequences.
Once in the hospital setting, the best outcomes will be
achieved for the patient when a multidisciplinary approach
is utilized [11]. In this practical guide, we review key
current frostbite literature, classification strategies and
recommendations for management of frostbite in the hos-
pital setting.
Literature search
A systematic literature search of the related articles pub-
lished between January 1969 and July 2013 was performed
using PubMed (restricted to the English language) with
keywords ‘frostbite’, ‘frostbite management’ and ‘freezing
cold injury’. The search included both human and animal
studies, original research, case series/reports, review arti-
cles and guidelines. Priority was given to human studies
and more recent publications since 2005. The studies were
identified by title and abstract and screened by the au-
thors; relevant cross-references were added.
Recommendation grade
Using the criteria defined by the American College of Chest
Physicians (ACCP), each form of intervention was attrib-
uted a recommendation grade where appropriate. For fur-
ther details on the criteria, please refer to Table 1 [12].Pre-hospital care and prevention
Prevention is always preferable, and education of those
working or recreating in cold environments should focus
on modification of risk factors, selection and use of proper
clothing, optimal nutrition and hydration [4]. Those work-
ing with equipment that uses coolant such as liquid nitro-
gen or carbon dioxide should also have adequate education
in safe handling of such products.
Whilst pre-hospital care is not the focus of this article,
key field management of frostbite concepts are summa-
rized in the following texts [13,14]. In general, the patient
should be moved out of the wind, provided with shelter
and be given warm fluids (recommendation grade 1C).Remove boots (but consider problems of replacement if
swelling occurs), and replace wet gloves and socks with
dry ones. Warm the cold extremity by placing it in a com-
panion's armpit or groin for 10 min and then replace the
boots/gloves. Rubbing the affected part is not recom-
mended because of the potential for worsening direct tis-
sue injury (recommendation grade 1C).
If sensation returns, the patient may mitigate risks (e.g.
add a layer and change to warmer or dryer socks or boots)
and continue to walk. If there is no return of sensation,
the injured should go to the nearest warm shelter (hut or
base camp) and seek medical treatment. If at high altitude
(>4,000 m), supplementary oxygen should be considered
[11] (recommendation grade 2C).
Aspirin 75 mg can be given for its rheologic effect.
Ibuprofen 12 mg/kg/day divided into two daily doses
(maximum of 2,400 mg/day) should be given for its
prostaglandin effect (recommendation grade 2C).
Field rewarming should only be attempted if there is
no further risk of refreezing [14,15]. Tissue that thaws
then refreezes results in more extensive injury (recom-
mendation grade 1B).
The decision to thaw the frostbitten tissue in the field
commits to a course of action that may involve pain
control, maintaining warm water baths at a constant
temperature, protecting tissue from further injury dur-
ing rewarming and eventual transport. In extreme cir-
cumstances, it may be better to let a casualty walk on a
frozen limb to safety rather than risk refreezing [16]
(recommendation grade 1C).
Hospital management
Immediate and general care for those admitted
with frostbite
On arrival to a hospital setting, it is vitally important to
fully reassess the patient. Underlying unstable comorbid-
ities, trauma or hypothermia must be assessed and man-
aged before frostbitten extremities are treated. Moderate
or severe hypothermia should be corrected to bring core
temperature above 35°C before initiating frostbite warm-
ing [14,17] (recommendation grade 1C).
A detailed history should include time the injury oc-
curred, either early (<24 h) or late (>24 h) as this will dic-
tate some treatment options. History of the conditions
surrounding the injury (i.e. temperature, wind chill, wet/
dry exposure, duration and use or not use of thermal pro-
tection) can also be helpful. Any pre-hospital treatment
and time of rewarming, if applicable, should be noted [14].
Remove jewellery from affected digits early as significant
swelling can be expected post thaw, and vascular com-
promise may occur with tight rings, etc. [14]. Examination
of the frostbitten tissue after rewarming can predict depth
of injury more accurately than examination before thaw-
ing. There may be different depths of injury even on digits
Table 1 ACCP classification criteria for grading evidence in clinical guideline [13]
Grade Description Benefits vs. risks and burdens Methodological quality of supporting evidence
1A Strong recommendation,
high-quality evidence
Benefits clearly outweigh risks
and burdens or vice versa
RCTs without important limitations or overwhelming
evidence from observational studies
1B Strong recommendation,
moderate-quality evidence
Benefits clearly outweigh risks
and burdens or vice versa
RCTs with important limitations or exceptionally
strong evidence from observational studies
1C Strong recommendation,
low-quality or very
low-quality evidence
Benefits clearly outweigh risks
and burdens or vice versa
Observational studies or case series
2A Weak recommendation,
high-quality evidence
Benefits closely balanced
with risks and burdens
RCTs without important limitations or overwhelming
evidence from observational studies
2B Weak recommendation,
moderate-quality evidence
Benefits closely balanced
with risks and burdens
RCTs with important limitations or exceptionally
strong evidence from observational studies
2C Weak recommendation,
low-quality or very
low-quality evidence
Uncertainty in the estimates of
benefits, risks and burden; benefits,
risk and burden may be closely balanced
Observational studies or case series
RCT, randomized controlled trial.
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mentation in either diagram form or with photographs are
useful. Clinical photography obviates the need for repeated
removal of dressings for each consultant examination, redu-
cing pain and risk of infection. Loss of sensation after
rewarming is a poor prognostic indicator, and the converse
is also true. Figure 1 suggests how one should proceed with
initial in hospital management.
Classification
There exist a number of frostbite classifications to assess
the severity and predict likely outcome. Cauchy et al. have
suggested a useful classification consisting of four grades
and three key descriptors (Table 2) [18]. At 24 h post in-
sult after rewarming, a grade can be attributed according
to the level of any visible lesion. Then, at day two, a tech-
netium99 triple-phase bone scan should be performed on
the more severe injuries (see Imaging section) and a fur-
ther assessment of any blisters undertaken. Injuries receiv-
ing grade 1 classification require no hospitalisation and
full recovery is likely. Grades 2 through 4 injuries require
hospitalisation and full investigation as they are associated
with an increased risk of amputation and long-term
sequelae [18].
Fluids
Rehydration can be oral or intravenous, and depending
upon severity and ability of the patient to tolerate oral
fluids. High altitude increases the risk of dehydration. If
the patient is also hypothermic, dehydration may be com-
pounded by cold diuresis due to suppression of antidiuretic
hormone, requiring correction with warmed intravenous
fluids (recommendation grade 1C).
Rewarming
Rewarming is beneficial if there remains a partially or
fully frozen part and is ideally accomplished using awhirlpool bath set at 38°C with added antiseptic solution
(povidone iodine or chlorhexidine). The Wilderness
Medical Society and State of Alaska Cold Injury Guide-
lines recommend a temperature of 37°C–39°C, which de-
creases the pain experienced by the patient whilst only
slightly slowing rewarming time [14,15]. The time period
for optimal rewarming varies from 15–30 min up to 1 h
[16]. Rewarming should continue until a red/purple colour
appears and the extremity tissue becomes pliable [14]. Ac-
tive motion during the rewarming process is beneficial,
but care should be taken to prevent the extremity from
touching the sides of the whirlpool. It is important to pro-
vide good analgesic cover and is likely to include narcotic
medication (recommendation grade 1B).
Blisters and dressings
It is important to note the type of any blisters that form;
they can be clear/cloudy or haemorrhagic in nature. There
is current debate as to whether blisters should be de-
roofed as this may desiccate the underlying tissue, but
there is little comparative data to settle this argument.
The recommended practice is that of selective drainage of
clear/cloudy blisters by needle aspiration (especially if bul-
lae restrict movement) and to leave haemorrhagic blisters
alone [14]. However, we would suggest that all blisters are
debrided in the hospital (not in the field) because we be-
lieve it assists with wound care. Severe injuries require de-
tailed assessment, and it may be that this appraisal and
debriding of blisters may be best performed under a gen-
eral anaesthetic (recommendation grade 2C).
Topical aloe vera cream or gel (a potent anti-
prostaglandin agent) should then be applied to thawed
tissue before dressings are applied [14] (recommenda-
tion grade 2C). Splinting, elevating and wrapping the
affected part in a loose, protective dressing with pad-
ding between affected patient's digits are ideal (recom-
mendation grade 1C).
Immediate hospital 
care
Yes Untreated systemic hypothermia
OR
Trauma
OR
Unstable comorbidities
No
Blisters
If clear consider 
aspiration
If haemorrhagic consider 
leaving 18
Simple non adhesive dry
dressings
Analgesia
Ibuprofen 400mg BD
Opiates as required
Treat
Rewarming of extremities
in waterbath at 37-39oC16
with added chlorhexadine or 
popovidone iodine for 30 
minutes20 to 1 hour14
Assessment of severity - Grades 1-4
Document severity for comparison after 
therapy
Photograph or Diagram of affected 
extremities
Figure 1 Immediate hospital management of frostbite injury.
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The role of prophylactic antibiotics is not proven but
should be considered in more severe injuries (grades 3
and 4) and, in particular, when associated with significant
oedema or malnutrition (homeless, chronic alcohol abuse
or return from extreme altitude). Systemic antibiotics areTable 2 Classification scheme for the severity of frostbite inju
Frostbite injuries of the extremity Grade 1 Grade 2
Extent of initial lesion
at day 0 after rewarming
Absence of initial lesion Initial lesion o
distal phalanx
Bone scanning at day 2 Useless Hypofixation
radiotracer up
Blisters at day 2 Absence of blisters Clear blisters
Prognosis at day 2 No amputation Tissue amput
No sequelae Fingernail seqrequired in the presence of proven infection, trauma or
cellulitis (recommendation grade 1C).
Tetanus toxoid
The need for tetanus toxoid administration should be
determined by following standard guidelines, asry [19]
Grade 3 Grade 4
n Initial lesion on intermediary
(and) proximal phalanx
Initial lesion on carpal/tarsal
of
take area
Absence of radiotracer
uptake on the digit
Absence of radiotracer uptake
area on the carpal/tarsal region
Haemorrhagic blisters
on the digit
Haemorrhagic blisters
over carpal/tarsal region
ation Bone amputation of digit Bone amputation of the limb
uelae Functional sequelae +/− systemic involvement
+/− sepsis functional sequelae
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wounds (recommendation grade 1C).
Analgesia and NSAIDs
Rewarming the extremities can become extremely painful,
so use of non-steroidal anti-inflammatory drugs or opiates
should be administered. Oral ibuprofen 12 mg/kg divided
over two daily doses provides systemic anti-prostaglandin
activity that limits the cascade of inflammatory damage.
This dose can be increased to a maximum of 2,400 mg/day
if the patient is experiencing pain and can be continued
until wounds are healed or amputation occurs. A dose of
400 mg BID is a practical regime on which to start most pa-
tients, and this can then be increased to 600 mg QDS as
pain dictates. If aspirin has not been given in the field (pro-
viding no contraindications), 300 mg once a day can be
given [4] (recommendation grade 2C).
Management specific to frostbite
For more superficial injuries, often, no more intervention
or investigation is required after basic treatment has been
initiated (Cauchy and Chetaille grade 1); however, in more
severe cases, further intervention is required. Advanced
imaging may be used to determine depth of tissue injury
and guide therapy. It will also give an accurate prognosis
at an early stage as to the subsequent likely clinical course.
This is important for the patient, clinicians and occasion-
ally for medico-legal reasons.
Imaging
For deep injuries, no surgical debridement should be
planned until imaging is performed. Many modalities have
been used, but angiography and technecium99 (99Tc) triple-Table 3 A proposed screening and treatment tool for the use
Treatment screen (four ‘yes’ answers required
to proceed to angiography)
Treatment protocol
Indications for stopping the infusion of the rTPA
Post lysis anticoagulationphase bone scanning give the best prognostic information
and will direct therapy [1] (recommendation grade 1C).
A retrospective review of 92 patients with severe
frostbite by Cauchy et al. [19] showed that 99Tc scans ob-
tained 2 days after the injury accurately predicted the
level of amputation in 84% of cases. 99Tc scanning has
been performed on the day of presentation [20]. Case re-
ports suggest magnetic resonance angiography (MRA) su-
periority to 99Tc as it allows direct visualization of
occluded vessels and surrounding tissue and may show a
clearer demarcation of ischaemic tissues, but this has yet
to be confirmed by larger studies [21]. However, MRA is
easier to access in many units, and there appears to be a
growing trend of using MRA as an alternative imaging
technique.Angiography and thrombolysis
A screening and treatment tool has been proposed for
the use of thrombolytics in frostbite (see Table 3) [17].
An initial selective diagnostic digital subtraction angiog-
raphy should be performed in patients being considered
for thrombolysis. Intravenous vasodilators (nitroglycerin
or papaverine) are useful (in conjunction with TPA) at this
stage in the treatment of the vasospasm that often accom-
panies a frostbite injury [17,22,23]. It is possible that non-
invasive MRA may offer a suitable alternative imaging mo-
dality (Figure 2).
In animal models, intravenous streptokinase limited
the extent of tissue damage in a hind limb of a rabbit
[24]. Streptokinase treatment and rapid rewarming re-
sulted in reduced tissue damage and was most beneficial
when given within 12 h of freezing and was still effective
even when treatment was delayed up to 48 h [24].of thrombolysis in cases of frostbite [17]
Questions/indications to be considered
Are the patient's gas exchange and haemodynamics stable?
Is flow absent after rewarming (no capillary refill or Doppler signals)?
Was the cold exposure time less than 24 h?
Is the warm ischaemia time less than 24 h?
Perform angiography with intra-arterial vasodilators
If there is still no flow after angiography with vasodilators, infuse tissue
plasminogen activator (rTPA) with systemic heparinization with priority
to the hands; other sites receive a systemic dose
Repeat angiography after 24 h
When restored flow has been confirmed by angiography or clinical
examination
If major bleeding complication occurs
After 72-h treatment
One month of subcutaneous low-molecular weight heparin
at prophylactic dose
Conservative 
management
No further 
investigations
Discharge
Follow up as 
outpatient 
Grade 1
Hospital 
management
> or < 24hrs
Grade 3/4
Technicium99
bone scan
Grade 
3/4
< 24hrs
Iloprost Infusion 
see figure 3b
Angiography
Thrombolysis with tPA as 
per hospital protocol
See figure 3a 
If expertise not 
available or no 
higher level care 
for monitoring 
thrombolysis 
transfer to 
tertiary hospital 
or use Iloprost
Grade 
3/4
Time from initial 
injury
The evidence for management of Grade 2 frostbite is unclear. Admission is 
likely to be necessary however the decision to use further intervention 
should be made on a case by case basis. 
Consider telemedicine consult.
Figure 2 Algorithm for the use of rTPA and iloprost in the management of frostbite injuries.
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to evaluate the safety and efficacy of tissue plasminogen
activator (rTPA) in the treatment of severe frostbite found
that rTPA and heparin after rapid rewarming is safe and
reduced predicted digit amputations. Similar efficacy was
reported in both the intravenous and intra-arterial delivery
arms [25]. Those patients with more than 24 h of cold
exposure, warm ischaemia times greater than 6 h or evi-
dence of multiple freeze-thaw cycles were least likely to
benefit [25].
Bruen et al. demonstrated a reduction in digital amputa-
tion rates from 41% in those patients that did not receive
rTPA to 10% in those receiving rTPA within 24 h of injury
(p < 0.05) [26]. It was also noted that efficacy after 24 h de-
creased. Thrombolysis within 24 h (early group) appears
to show the best outcomes in digit salvage [17]; however,
thrombolysis after 24 h should be considered on an indi-
vidual risk-benefit basis.
Delivery of rTPA can be either intravenous (IV) or via
catheter-directed intra-arterial (IA) administration [17,25,26].The latter is our preferred route, if rTPA is to be used ra-
ther than iloprost. Normal contraindications to TPA apply
including existing trauma, recent surgery, neurological im-
pairment or bleeding diathesis. It is not appropriate for
superficial frostbite (grade 1), only deep tissue injuries that
affect more proximal phalanges and the forefoot or foot
should be considered, as treatment is not without risks of
haemorrhage [17].
rTPA delivery should be provided at a centre accus-
tomed to performing thrombolysis and that can
provide adequate monitoring (usually in a critical care/
high-dependency setting). If the patient presents
less than 24 h after injury to a hospital without these fa-
cilities, consider urgent transfer in order not to delay
commencement of therapy. rTPA is used in combination
with heparin, which reduces the recurrence of micro-
vascular thrombosis.
Repeat angiograms should be performed every 12–24 h
to evaluate response to therapy. rTPA treatment should be
discontinued when perfusion is restored to distal vessels
Monitoring during rTPA infusion
Pulse/BP every 30mins
No intramuscular injections during rTPA
Vascular consultant/radiologist to decide duration of rTPA infusion
If concerns regarding complications – contact on call team immediately
Do not discontinue rTPA infusion for more than 10 mins (thrombus can form very quickly on catheters)
Intra-arterial thrombolysis with rTPA AND concurrent Heparin infusion 
via a single puncture dual port sheathe
Stop heparin and leave sheath in situ for 
2 hrs.
Remove sheath and apply firm direct 
pressure to puncture site with gauze 
for 20mins.
If bleeding occurs after pressure then 
apply further pressure for 20mins
If further bleeding contact Consultant 
Vascular surgeon and continue with 
application of pressure to puncture 
site
Label each syringe with patient details, drug 
details, date/time of creation.
Keep solution in fridge and can be kept for 
maximum of 24hrs
30ml bolus over 15mins (3mg) followed by 
constant infusion of 10mls/hr (1mg)
Check radiologists notes prior to 
commencing this for any adjustments
When rTPA is stopped usually at check 
angiogram the catheter is removed, leaving 
the sheath in situ (see heparin arm for 
further instructions
Run continuously at 5mls/hr. = 
500units/hr. 
Not necessary to monitor APTTR on this 
dose
Step 2
Take 4x 60mls syringes with Luer lock 
ends.
Put 6mls of 1mg/ml solution into each 
syringe (discard the rest)
Fill the remainder of syringes of 60mls with 
normal saline (i.e. add 54mls to each)
Final concentration of 0.1mg/ml for the 
infusion.
Once rTPA stopped introducer sheath is 
left in situ with heparin infusion still 
running through it – leave for 4 hours
Step 1
Use 50mg vials of rTPA
Comes as to vials – 1 with powder, 1 with 
the solvent.
Mix the 2 together with spiked connector 
provided. See diagram in leaflet
1mg/ml (50mg in 50mls)
Use 1ml of 5000units/ml concentration 
into 50ml syringe and top up to 50ml 
with normal saline
Heparin
(Via side port of introduced sheath)
rTPA – Alteplase
(Via end port of catheter)
a
b
Contraindications
Unstable angina; < 6 months of myocardial infarction; 
cardiac failure; severe arrhythmias; within 3 months of 
cerebrovascular events; conditions which increase risk of 
bleeding
Side Effects
Headache
Hypotension
Flushing
Palpitations
Iloprost 
administation
Syringe 
Driver 
(preferred 
method)
Infusion 
pump
100mcg of Iloprost with 
500mls normal saline or 
5% Dextrose
Days 1-3
Start at 1ml/hr and 
titrate upwards by 
1ml/hr every 
30mins-1hr
Check BP and P 
30 minutes after 
starting infusion.
If intolerable side 
effects reduce rate 
by 1ml/hr until side 
effects tolerable
100mcg of Iloprost with 
50ml of Normal Saline or 
5% dextrose
Days 1-3
Start at 10ml/hr 
and titrate 
upwards by 
10ml/hr every 
30mins-1hr
Check BP and P 
30 minutes after 
starting infusion.
If intolerable side 
effects reduce rate 
by 1ml/hr until  
side effects 
tolerable
Days 4-6
No need to 
titrate upwards. 
Start at 
optimum rate
Figure 3 Intra-arterial administration of rTPA and heparin and
administration of intravenous iloprost. (a) Algorithm for the
intra-arterial administration of tTPA and heparin for in-hospital
thrombolysis of severe frostbite injury. (b) Algorithm for the
administration of intravenous iloprost for in-hospital thrombolysis
of severe frostbite injury.
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gives a stepwise approach to intra-arterial thrombolysis
(recommendation 1B-C).
Iloprost
Iloprost is a prostacyclin analogue with vasodilatory prop-
erties that mimic the effects of a sympathectomy [27]. It
may also affect platelet aggregation and therefore decrease
microvascular occlusion. Unfortunately, intravenous ilo-
prost is not currently available in the USA.
In 1994, Groechenig published his experience in treating
four cases of severe frostbite with iloprost [28]. The results
were promising, with no patients requiring amputation;
however, since these initial findings were published, the
focus has shifted towards rTPA, with no further data pub-
lished on iloprost use until a recent paper by Cauchy et al
[29]. In a randomized controlled trial designed to compare
the efficacy of iloprost and rTPA, 47 patients were included
with a total of 407 digits at risk. All patients underwent
identical initial treatment and rewarming and then were
randomized into three arms: buflomedil, iloprost or iloprost
and IV rTPA. The risk of amputation on the buflomedil
arm was the greatest with 39.9% of at-risk digits requiring
amputation. In the iloprost and iloprost/rTPA arms, the
amputation rates were 0% and 3.1%, respectively [29].
The administration of iloprost is via an IV infusion. The
dose used is 0.5 up to a maximum of 2 ng/kg/min [29], in-
crementally increased every 30 min by 0.5 ng/kg/min until
the patient develops unacceptable or intolerable side ef-
fects (headache and hypotension). The rate is then re-
duced by 0.5 ng/kg/min. The infusion is continued for 6
h/day for 5–8 days at the previously determined maximal
rate a patient can tolerate.
The advantages of iloprost compared to rTPA are that it
does not require radiological intervention during adminis-
tration and can be managed on a general or vascular ward.
Iloprost can be used when there is a history of trauma or
when the exposure occurred over 24 h ago, unlike rTPA
where trauma is a contraindication and efficacy is reduced
beyond 24 h. Figure 3b gives a stepwise approach to ilo-
prost administration (recommendation grade 1B).
Surgery
Immediate amputation should be avoided; there is rarely
any need for early intervention unless there is wet gan-
grene, liquefaction, overwhelming infection or spreading
sepsis [30,31]. Planning is vital with a goal of obtaining the
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morbidity and is likely to lead to poor subsequent function
(recommendation grade 1C).
Fasciotomies are occasionally required post thaw if re-
perfusion is compromised by compartment syndrome [31]
(recommendation grade 1C). The majority of amputations
can be performed 6–12 weeks post injury once demarca-
tion of ischaemic tissue has been well defined [4]. Negative
pressure devices can aid in speeding up healing of amputa-
tion sites when left to heal by secondary intention [32].
Tissue protection
During the demarcation period, it is important to pro-
vide adequate protection especially footwear. Therefore,
liaison with orthotic/podiatry department to provide be-
spoke footwear that protects and also attempts to main-
tain limb function is vital.
Following amputation, function is variable and injury
specific. The biomechanics of the foot/hand can be radic-
ally altered and frostbite neuropathy can compound the
problem; so, again, custom-made footwear may be re-
quired to optimize the long-term functional result and
minimize secondary injuries [33].
Adjunctive therapies
The below therapies have insufficient trials performed to
present any cognizant argument for their use but have
been described in case reports or animal studies.
Hyperbaric oxygen therapy By increasing oxygen ten-
sion in the blood, more oxygen is delivered to the tis-
sues; however, this requires patent microvasculature.
Hyperbaric oxygen therapy (HBOT) increases the
deformability of erythrocytes, diminishes oedema forma-
tion in burns and post ischaemic tissues and has some
bacteriostatic properties [34].
HBOT in frostbite has had mixed results with no level
1 evidence available. Animal studies have demonstrated
no benefit [35], yet two recent human case series have
yielded excellent results [34,36]. Significant thrombosis
of the microvasculature may be the cause of its variable
effect. Thus, currently, there is insufficient data to rec-
ommend its routine use (no recommendation grade due
to insufficient evidence).
Sympathectomy Surgical or chemical sympathectomy
has yielded mixed results in improving blood flow. Early
sympathectomy performed within the first few hours of
injury is said to increase oedema formation and, conse-
quently, tissue loss; however, if performed 24–48 h after
thawing, resolution of oedema and decreased tissue loss
are observed [37].
Sympathectomy may have a role in managing long-
term sequelae of frostbite such as pain (often due tovasospasm), paraesthesias and hyperhidrosis [37]. How-
ever, since sympathectomy is irreversible, great caution
should be exercised when considering its use, given the
availability of alternative IV vasodilators [11] (no recom-
mendation grade due to insufficient evidence).
Long-term management
The long-term sequelae of frostbite are less well studied.
However, it is known that the tissue, which has recov-
ered from frostbite, may be more susceptible to subse-
quent freezing injury. Consequently, patients should be
educated about this risk especially if they plan to return
to cold environments.
A long-term follow-up study of 30 patients with sig-
nificant frostbite injuries showed that 53% exhibited
cold hypersensitivity, 40% numbness of the digits and
33% had reduced sensitivity to touch [37]. The study
postulates that these side effects may be secondary to a
thermo-physiological response with an increased ten-
dency to vasospasm. With this cold sensitization, the
individual may be unable to tolerate cold temperature
upon the previously frostbitten area, even when other
body areas are comfortable at that temperature [38].
Chronic regional pain is perhaps the most common
complaint post frostbite. The pain is often unresponsive
to conventional analgesia and may be lifelong. Medica-
tions such as amitriptyline or gabapentin may have some
benefit, but referral to a chronic pain specialist should
be made in these cases.
Localized osteoporosis and sub-chondral bone loss can
be seen post injury and reflect the severity of vascular
damage. Changes can be seen within a month of injury
but often progress over months such that by 16 months,
radiographs can reveal multiple lucencies in the sub-
chondral bone [39]. In children, the damage may be more
significant with undergrowth of affected bone and devel-
opment of early arthritis [39,40].
Skin areas that have been affected by frostbite are sus-
ceptible to chronic ulceration due to poor tissue quality
after healing and can undergo a malignant transform-
ation akin to the formation of Marjolin's ulcers observed
in old burn scars [41].
Accessing expert advice (telemedicine)
Patients and clinicians with limited experience of frost-
bite can now use the internet and satellite phones to ac-
cess expert advice in remote or difficult situations. A
virtual opinion or more specialized advice can be sought
from almost anywhere in the world using a combination
of digital images and telephone advice [4,11,42,43].
Conclusions
Deep frostbite is a serious condition that is associated
with significant morbidity, and it is becoming more
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at risk. Timely pre-hospital and definitive hospital man-
agement are important to minimize final tissue loss and
maximize functionality of the affected limb.
Surgeons should not to rush to early amputation; if
managed correctly in the first few days, significant
tissue can be salvaged, which is very important to the
final functional outcome. We have outlined a series of
management frameworks, which we hope will enable
surgeons who rarely see this condition to have a greater
understanding of frostbite and its management.
Either intravenous iloprost or thrombolysis with rTPA
should be considered in all patients who present within
24 h of sustaining an appropriately severe injury and if the
facility is capable of appropriate administration and moni-
toring. Both treatments should be started as soon as it is
practical to gain maximal benefit. There is some evidence
iloprost can be used beyond the 24 hour window and it is
the treatment of choice where there are contraindications
to thrombolysis. Bone scanning is helpful to ascertain deep
tissue injury and response to therapy.
If iloprost is an available option (and it is not currently
available in USA), then iloprost is the preferred option
based upon its simplicity of administration, safety and
efficacy. Prevention with education, behaviour modifica-
tion and appropriate use of suitable equipment is im-
portant to reduce frostbite incidence.
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